Diag-Nose.io

Melbourne, Australia

Diag-Nose.io is on a mission to eliminate respiratory disease by decoding the airway’s molecular pathways.

Aug 2025

Grant

Biotechnology Health Care Health Diagnostics Medical

Top Investors

Artesian VCBreakthrough VictoriaRadar VenturesSpecialty Physician AssociatesCooperative Research Centre Projects

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Diag-Nose.io

Who are Diag-Nose.io's investors?

Diag-Nose.io's investors include Artesian VC, Breakthrough Victoria, Radar Ventures, Specialty Physician Associates, Cooperative Research Centre Projects.

Where is Diag-Nose.io headquartered?

Diag-Nose.io is headquartered in Melbourne, Australia.

What does Diag-Nose.io do?

Diag-Nose.io is on a mission to eliminate respiratory disease by decoding the airway’s molecular pathways.

What stage is Diag-Nose.io at?

Diag-Nose.io is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 15, 2025.

MLA

"Diag-Nose.io — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/diag-noseio. Accessed July 1, 2026.

APA

VCBacked. (2025). Diag-Nose.io — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/diag-noseio

Wikipedia (cite web)

{{cite web |title=Diag-Nose.io — Funding & Investors |url=https://www.vcbacked.co/company/diag-noseio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 15, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.